Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The U.S. Department of Health and Human Services and the National Institutes of Health made an announcement of the latest ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.